{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:57:15Z","timestamp":1785491835873,"version":"3.56.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ando.2016.01.010","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T02:06:26Z","timestamp":1466042786000},"page":"226-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["SFE\/SFHTA\/AFCE consensus on primary aldosteronism, part 7: Medical treatment of primary aldosteronism"],"prefix":"10.1016","volume":"77","author":[{"given":"Antoinette","family":"Pech\u00e8re-Bertschi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Herpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2016.01.010_bib0005","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1210\/jc.2008-2803","article-title":"Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience","volume":"94","author":"Sukor","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.01.010_bib0010","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","article-title":"Efficacy and tolerance of spironolactone in essential hypertension","volume":"60","author":"Jeunemaitre","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ando.2016.01.010_bib0015","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.01.010_bib0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.amjhyper.2005.06.031","article-title":"Aldosterone and refractory hypertension: a prospective cohort study","volume":"19","author":"Sartori","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ando.2016.01.010_bib0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-131-2-199907200-00005","article-title":"Medical management of aldosterone-producing adenomas","volume":"131","author":"Ghose","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ando.2016.01.010_bib0030","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1365-2125.1999.00070.x","article-title":"Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study","volume":"48","author":"Lim","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ando.2016.01.010_bib0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1530\/EJE-12-0912","article-title":"Long-term re-evaluation of primary aldosteronism after medical treatment reveals high proportion of normal mineralocorticoid secretion","volume":"168","author":"Lucatello","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2016.01.010_bib0040","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1210\/jc.2011-2563","article-title":"Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy","volume":"97","author":"Yoneda","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.01.010_bib0045","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2265.2011.04243.x","article-title":"Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: results from the German Conn's registry","volume":"76","author":"Fischer","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2016.01.010_bib0050","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ando.2016.01.010_bib0055","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/ndt\/gfs587","article-title":"Regression of left ventricular hypertrophy in patients with primary aldosteronism\/low-renin hypertension on low-dose spironolactone","volume":"28","author":"Ori","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ando.2016.01.010_bib0060","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2016.01.010_bib0065","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ajh.2010.169","article-title":"Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment","volume":"23","author":"Sechi","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ando.2016.01.010_bib0070","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2215\/CJN.00050107","article-title":"Relationships of plasma renin levels with renal function in patients with primary aldosteronism","volume":"2","author":"Catena","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ando.2016.01.010_bib0075","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/HJH.0b013e328126855b","article-title":"Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment","volume":"25","author":"Novello","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2016.01.010_bib0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1530\/EJE-12-0631","article-title":"Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism","volume":"168","author":"Fourkiotis","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2016.01.010_bib0085","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7326\/0003-4819-87-4-398","article-title":"Pathophysiology of spironolactone-induced gynecomastia","volume":"87","author":"Rose","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ando.2016.01.010_bib0090","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2016.01.010_bib0095","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/HJH.0b013e3283455ca5","article-title":"A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism","volume":"29","author":"Parthasarathy","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2016.01.010_bib0100","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1517\/14656566.9.4.509","article-title":"Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism","volume":"9","author":"Karagiannis","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ando.2016.01.010_bib0105","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2016.01.010_bib0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/clpt.1982.9","article-title":"Amiloride in primary hyperaldosteronism","volume":"31","author":"Griffing","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ando.2016.01.010_bib0115","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/clpt.1981.155","article-title":"Triamterene-thiazide combination: alternative therapy for primary aldosteronism","volume":"30","author":"Ganguly","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ando.2016.01.010_bib0120","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/HYPERTENSIONAHA.107.103580","article-title":"A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity","volume":"51","author":"Dietz","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2016.01.010_bib0125","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/HJH.0b013e32835d6d49","article-title":"Sequential comparison of aldosterone synthase inhibition and mineralocorticoid blockade in patients with primary aldosteronism","volume":"31","author":"Amar","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2016.01.010_bib0130","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1021\/jm100506y","article-title":"Discovery of novel cyanodihydropyridines as potent mineralocorticoid receptor antagonists","volume":"53","author":"Arhancet","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.ando.2016.01.010_bib0135","first-page":"274","article-title":"Cardiovascular changes in patients with primary aldosteronism after surgical or medical treatment","volume":"35","author":"Bernini","year":"2012","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.ando.2016.01.010_bib0140","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/ajh.2008.243","article-title":"Adrenalectomy improves arterial stiffness in primary aldosteronism","volume":"21","author":"Strauch","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ando.2016.01.010_bib0145","first-page":"21","article-title":"Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment","volume":"108","author":"Sindelka","year":"2000","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ando.2016.01.010_bib0150","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.27.5.1039","article-title":"Changes in left ventricular anatomy and function in hypertension and primary aldosteronism","volume":"27","author":"Rossi","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2016.01.010_bib0155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","article-title":"Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study","volume":"25","author":"Giacchetti","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2016.01.010_bib0160","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ando.2016.01.010_bib0165","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1681\/ASN.2004100878","article-title":"Relative glomerular hyperfiltration in primary aldosteronism","volume":"16","author":"Ribstein","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ando.2016.01.010_bib0170","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1210\/jc.2008-2245","article-title":"Intrarenal hemodynamics in primary aldosteronism before and after treatment","volume":"94","author":"Sechi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.01.010_bib0175","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/jc.2008-1851","article-title":"Risk factors associated with a low glomerular filtration rate in primary aldosteronism","volume":"94","author":"Reincke","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.01.010_bib0180","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","article-title":"Long-term renal outcomes in patients with primary aldosteronism","volume":"295","author":"Sechi","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2016.01.010_bib0185","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cca.2011.02.018","article-title":"Kidney impairment in primary aldosteronism","volume":"412","author":"Wu","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ando.2016.01.010_bib0190","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1097\/HJH.0b013e3283495cbb","article-title":"Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment","volume":"29","author":"Wu","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2016.01.010_bib0195","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1470320310391331","article-title":"Relative kidney hyperfiltration in primary aldosteronism: a meta-analysis","volume":"12","author":"Kuo","year":"2011","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.ando.2016.01.010_bib0200","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/bmj.291.6501.1047-b","article-title":"Incidence of hyperkalaemia induced by indomethacin","volume":"291","author":"de Jong","year":"1985","journal-title":"BMJ Clin Res"},{"key":"10.1016\/j.ando.2016.01.010_bib0205","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/FTD.0b013e31818b0e6a","article-title":"Effect of spironolactone, potassium canrenoate and their common metabolite canrenone on serum digoxin measurement by digoxin III, a new digoxin immunoassay","volume":"30","author":"Dasgupta","year":"2008","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ando.2016.01.010_bib0210","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1210\/jcem.85.12.7086","article-title":"Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma","volume":"85","author":"Phillips","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.01.010_bib0215","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2016.01.010_bib0220","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.11.2011.5238","article-title":"Spironolactone, a possible selective androgen receptor modulator, should be used with caution in patients with metastatic carcinoma of the prostate","author":"Sundar","year":"2012","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ando.2016.01.010_bib0225","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1158\/0008-5472.CAN-11-3980","article-title":"Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100","volume":"72","author":"Richards","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.ando.2016.01.010_bib0230","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1124\/dmd.30.12.1344","article-title":"Involvement of CYP3A in the metabolism of eplerenone in humans and dogs: differential metabolism by CYP3A4 and CYP3A5","volume":"30","author":"Cook","year":"2002","journal-title":"Drug Metab and Dispos"},{"key":"10.1016\/j.ando.2016.01.010_bib0235","doi-asserted-by":"crossref","first-page":"d5228","DOI":"10.1136\/bmj.d5228","article-title":"Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study","volume":"343","author":"Antoniou","year":"2012","journal-title":"BMJ Clin Res"},{"key":"10.1016\/j.ando.2016.01.010_bib0240","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/HYPERTENSIONAHA.111.187237","article-title":"Eplerenone use in primary aldosteronism during pregnancy","volume":"59","author":"Cabassi","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2016.01.010_bib0245","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1440-1797.2010.01396.x","article-title":"Eplerenone for Gitelman syndrome in pregnancy","volume":"16","author":"Morton","year":"2011","journal-title":"Nephrology"},{"key":"10.1016\/j.ando.2016.01.010_bib0250","first-page":"e4447","article-title":"Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study","volume":"345","author":"Mackenzie","year":"2012","journal-title":"BMJ Clin Res"},{"key":"10.1016\/j.ando.2016.01.010_bib0255","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/bmj.38883.479549.2F","article-title":"Spironolactone and risk of upper gastrointestinal events: population based case-control study","volume":"333","author":"Verhamme","year":"2006","journal-title":"BMJ Clin Res"},{"key":"10.1016\/j.ando.2016.01.010_bib0260","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2125.2008.03205.x","article-title":"Spironolactone use and the risk of upper gastrointestinal bleeding: a population-based case-control study","volume":"66","author":"Gulmez","year":"2008","journal-title":"Br J Clin Pharmacol"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426616300439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426616300439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:48:34Z","timestamp":1757717314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426616300439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0003426616300439"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2016.01.010","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SFE\/SFHTA\/AFCE consensus on primary aldosteronism, part 7: Medical treatment of primary aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2016.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}